No more than 15 authors can be listed.Please ensure the authors are listed in the right order.If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.
COPD is a leading cause of mortality and morbidity, with frequent exacerbations that can lead to acute respiratory failure. NIV is a key treatment for acute respiratory failure in ECOPD. BUN/Albumin ratio has been proposed as a prognostic marker in various diseases, reflecting metabolic stress and systemic inflammation. Still, its association with the need for NIV in ECOPD has not been widely studied.
This study aims to evaluate the association between the BUN/Albumin ratio and the need for NIV in patients with ECOPD.
This cross-sectional study was conducted in the inpatient department of Respiratory Medicine at the National Institute of Diseases of the Chest & Hospital, Dhaka, Bangladesh, from September 2023 to March 2025. A total of 116 patients diagnosed with ECOPD were enrolled. The BUN/Albumin ratio was measured for each patient, and the need for NIV was assesed. Data were analysed to determine if there was a significant association between the BUN/Albumin ratio and the need for NIV.
The mean BUN/Albumin ratio was significantly higher (9.2+-2.1) in patients who NIV compared to those who did not (5.3+-1.8), p=0.001. A progressive increase in the BUN/Albumin ratio was observed with worsening severity of ECOPD, with severe cases showing the highest ratios ( 9.5+-2.9). Multivariate regression analysis showed that the BUN/Albumin ratio was significantly associated with the need for NIV ( adjusted OR 19.629, 95% CI 13.976-27.561, p=0.001).
The BUN/Albumin ratio is significantly associated with the need for NIV in patients with ECOPD.